• Episurf Medical signed a letter of intent with Canada's Oligo Medic for the potential sale of its medical technology business.
• The proposed sale supports a shift toward real estate, following a strategic review disclosed on October 26, 2026.
• Oligo Medic plans to integrate the business into its joint-preservation treatment platform, FOREVER IN MOTION.
• No sale has been completed; a transaction remains subject to a definitive agreement and required approvals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Episurf Medical AB published the original content used to generate this news brief via Cision (Ref. ID: 202610260930BITN____UKPR__SV_20261026-BIT-9974-0) on October 26, 2026, and is solely responsible for the information contained therein.